Our findings reveal that ALDH1A1 overexpression in tumor cells correlates with prolonged patient survival in iCC, contradicting its typical association with higher tumorigenicity 54,55, and cancer stem cells 56. The gene discussed is ALDH1A1; the disease is intrahepatic cholangiocarcinoma.